Parallax Volatility Advisers
ONC

Parallax Volatility Advisers’s BeOne Medicines Ltd ONC Stock Holding History

Parallax Volatility Advisers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,397
Closed -$1.51M – 3480
2021
Q2 		$1.51M Sell
4,397
-2,099
-32% -$695K ﹤0.01% 1761
2021
Q1 		$2.26M Buy
+6,496
New +$2.15M ﹤0.01% 1676
2019
Q3 		– Sell
-20
Closed -$2K – 3669
2019
Q2 		$2K Buy
+20
New +$2.54K ﹤0.01% 2406

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Parallax Volatility Advisers's ONC Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of BeOne Medicines Ltd (ONC) in Q3 2021, closing a stake of 4,397 shares — an estimated $1.51M sold.

Parallax Volatility Advisers first reported a position in ONC in Q2 2019 and held it in 3 quarters. The position peaked at $2.26M in Q1 2021. 254 funds tracked by Wall St. Rank hold ONC as of Q3 2021.

  • Parallax Volatility Advisers reported no remaining BeOne Medicines Ltd position as of Q3 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 4,397 BeOne Medicines Ltd shares in Q3 2021, an estimated $1.51M.
  • Parallax Volatility Advisers first reported a position in BeOne Medicines Ltd in Q2 2019 and held it in 3 quarters.
  • Parallax Volatility Advisers's BeOne Medicines Ltd position peaked at $2.26M in Q1 2021.
  • 254 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.